Perrigo Newsroom

Perrigo (PRGO.US) will release its Earnings Reports on May 7.

$Perrigo (PRGO.US)$ will release its Earnings Reports on May 7th, investors please pay attention. How were the previous results? $Perrigo (PRGO.US)$ had a revenue of 1.138 billion USD in Q4 2024, a Net income of -44.5 million USD, and an EPS of -0.32 USD. In Q1 2024, the revenue was 1.082 billion USD, a Net income of 2 million USD, and an EPS of 0.01 USD. The accounting standards used for the above data are US_GAAP. Futubull prompts: 1. There are no strict regulations on the fiscal year classification for listed companies in Hong Kong and the U.S., completely.

Moomoo NewsMay 1 21:00 ET

Perrigo To Go Ex-Dividend On May 30th, 2025 With 0.29 USD Dividend Per Share

Moomoo NewsApr 30 19:35 ET

Perrigo Keeps Quarterly Dividend at $0.29 a Share, Payable June 17 to Investors of Record May 30

MT NewswiresApr 30 12:32 ET

Press Release: Perrigo Announces Quarterly Dividend

Dow JonesApr 30 10:24 ET

Is Perrigo (NYSE:PRGO) A Risky Investment?

Simply Wall StApr 28 15:17 ET

Perrigo to Release First Quarter 2025 Financial Results on May 7, 2025

PR NewswireApr 23 16:47 ET

J.P. Morgan Maintains Perrigo(PRGO.US) With Buy Rating, Maintains Target Price $38

Moomoo NewsApr 22 02:31 ET · Ratings

Trump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan

BenzingaApr 21 14:38 ET

AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."

① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.

cls.cnApr 11 07:59 ET

Perrigo on Pace for Largest Percent Decrease Since May 2024 -- Data Talk

Dow JonesApr 8 12:41 ET

Insiders At Perrigo Sold US$2.3m In Stock, Alluding To Potential Weakness

Simply Wall StApr 2 07:17 ET

Trump's Medical Tariffs Could Significantly Hurt These European Healthcare Firms

Seeking AlphaMar 29 11:38 ET

Hospital Stocks Are Ready to Rebound, Deutsche Bank Says

BNN BloombergMar 25 13:51 ET

Proposed Medicaid Cuts Would Devastate Local Economies: Report -- Barrons.com

Barron'sMar 25 00:01 ET

The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.

Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.

Zhitong FinanceMar 18 03:00 ET

New York Manufacturing Hits Low, Inflation Fears Rise

InvestingMar 17 08:50 ET

Insider Sale: EVP of $PRGO Sells 7,800 Shares

Quiver QuantitativeMar 10 20:16 ET

Trending Stocks Today | Plus Therapeutics Inches up 7.63% Post-Market

Moomoo NewsMar 6 16:25 ET

Perrigo To Go Ex-Dividend On March 7th, 2025 With 0.29 USD Dividend Per Share

Moomoo NewsMar 5 20:00 ET

Perrigo (NYSE:PRGO) Shareholders Are up 15% This Past Week, but Still in the Red Over the Last Five Years

Simply Wall StMar 4 13:17 ET